Medical Document Management System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Af
Description
Medical Document Management System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global medical document management systems market is poised for remarkable growth, with a projected value of US$ 2.6 billion by 2031, according to a new report. In 2024, the market was valued at US$ 1.2 billion. Key drivers propelling this expansion include increased government initiatives for healthcare IT technology implementation and a surge in mergers and acquisitions among healthcare IT companies.
Demand Drivers for the Medical Document Management Systems Market
“Increased Government Initiatives for Implementation of Healthcare IT Technologies”
Governments worldwide are actively promoting the adoption of various IT technologies in the healthcare sector. This initiative, along with a rising number of hospitalizations globally, is expected to fuel the demand for medical document management systems. Accurate patient data maintenance is becoming increasingly crucial in the healthcare industry.
“Increasing Mergers & Acquisitions among Healthcare IT Companies”
Healthcare IT companies are embracing growth strategies, with mergers and acquisitions being a prominent approach. This trend is expanding their global presence and enhancing their capabilities.
Challenges Hindering Wider Adoption of Medical Document Management Systems
“Dearth of Healthcare IT Professionals in Many Regions”
A shortage of healthcare IT professionals, particularly in developing regions, is a significant constraint to market growth. Additionally, concerns related to data security and privacy in document management systems are limiting expansion opportunities, with data security breaches being a growing concern.
Leading Region in the Global Medical Document Management Systems Market
“Improved Healthcare Infrastructure in North America Drives Avenues”
North America is expected to lead the global medical document management systems market, primarily due to increased government funding for healthcare facilities and a well-developed healthcare infrastructure. Technological advancements, including the adoption of Electronic Health Records (EHRs), are further propelling growth in this region.
South Asia and the Pacific, as well as East Asia, are forecasted to experience rapid growth. Regional governments are spearheading IT technology implementation in healthcare, coupled with pressure on healthcare organizations to improve care quality and reduce costs. Japan, China, and India are identified as the fastest-growing countries in the Asian market.
Key Market Players
Prominent companies driving the medical document management systems market include:
• 3M Company
• McKesson Corporation
• Siemens AG
• Hyland Software, Inc.
• Epic Systems Corporation
• Kofax Limited
• Toshiba Medical Systems Corporation
• Cerner Corporation
• Allscripts Healthcare Solutions, Inc.
• GE Healthcare
Medical Document Management Systems Industry Research by Category
By Delivery Mode:
• On-premise
• Cloud-based
• Web-based
By Product:
• Solutions
• Services
By Application:
• Patient Billing Document Management
• Patient Medical Record Management
• Admission and Registration Document Management
By End User:
• Hospitals and Clinics
• Government Organization and Third Party Administration (TPAs)
• Nursing Homes
• Others
By Region:
• North America
• Europe
• Latin America
• East Asia
• The Middle East & Africa
• South Asia & Pacific
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Peripheral Vascular Devices Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value and Volume, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Production Output and Trade Statistics, 2018 – 2023
- 3.1. Global Peripheral Vascular Devices Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 – 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa
- 4. Price Analysis, 2018 – 2023
- 4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2018 – 2023
- 4.2. Prominent Factor Affecting Peripheral Vascular Devices Prices
- 4.3. Global Average Price Analysis, by Region, US$ Per Unit
- 5. Global Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 5.1. Global Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Peripheral Vascular Stents
- 5.1.1.1.1. Self-Expanding Stents
- 5.1.1.1.2. Balloon Expanding Stents
- 5.1.1.1.3. Covered Stents
- 5.1.1.1.4. Drug Eluting Stents
- 5.1.1.2. Drug Eluting Balloons
- 5.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 5.2. Global Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Target Artery Instability (TAI)
- 5.2.1.2. Access Artery Injury (AAI)
- 5.2.1.3. Peripheral Arterial Disease
- 5.2.1.4. Arteriovenous Fistulas
- 5.2.1.5. Peripheral Aneurysms
- 5.2.1.6. Others
- 5.3. Global Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Carotid Artery
- 5.3.1.2. Fem-Pop Artery
- 5.3.1.3. Iliac Artery
- 5.3.1.4. Infrapop Artery
- 5.4. Global Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Hospitals
- 5.4.1.2. Ambulatory Surgical Centers/Outpatients
- 5.4.1.3. Cardiac Catheterization Labs
- 5.5. Global Peripheral Vascular Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. North America
- 5.5.1.2. Europe
- 5.5.1.3. Asia Pacific
- 5.5.1.4. Latin America
- 5.5.1.5. Middle East & Africa
- 6. North America Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 6.1. North America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Peripheral Vascular Stents
- 6.1.1.1.1. Self-Expanding Stents
- 6.1.1.1.2. Balloon Expanding Stents
- 6.1.1.1.3. Covered Stents
- 6.1.1.1.4. Drug Eluting Stents
- 6.1.1.2. Drug Eluting Balloons
- 6.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 6.2. North America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Target Artery Instability (TAI)
- 6.2.1.2. Access Artery Injury (AAI)
- 6.2.1.3. Peripheral Arterial Disease
- 6.2.1.4. Arteriovenous Fistulas
- 6.2.1.5. Peripheral Aneurysms
- 6.2.1.6. Others
- 6.3. North America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Carotid Artery
- 6.3.1.2. Fem-Pop Artery
- 6.3.1.3. Iliac Artery
- 6.3.1.4. Infrapop Artery
- 6.4. North America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Hospitals
- 6.4.1.2. Ambulatory Surgical Centers/Outpatients
- 6.4.1.3. Cardiac Catheterization Labs
- 6.5. North America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. U.S. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.2. U.S. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.3. U.S. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.4. U.S. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.5. Canada Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.6. Canada Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.7. Canada Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.1.8. Canada Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Europe Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 7.1. Europe Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Peripheral Vascular Stents
- 7.1.1.1.1. Self-Expanding Stents
- 7.1.1.1.2. Balloon Expanding Stents
- 7.1.1.1.3. Covered Stents
- 7.1.1.1.4. Drug Eluting Stents
- 7.1.1.2. Drug Eluting Balloons
- 7.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 7.2. Europe Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.2.1. Key Highlights
- 7.2.1.1. Target Artery Instability (TAI)
- 7.2.1.2. Access Artery Injury (AAI)
- 7.2.1.3. Peripheral Arterial Disease
- 7.2.1.4. Arteriovenous Fistulas
- 7.2.1.5. Peripheral Aneurysms
- 7.2.1.6. Others
- 7.3. Europe Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Carotid Artery
- 7.3.1.2. Fem-Pop Artery
- 7.3.1.3. Iliac Artery
- 7.3.1.4. Infrapop Artery
- 7.4. Europe Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Hospitals
- 7.4.1.2. Ambulatory Surgical Centers/Outpatients
- 7.4.1.3. Cardiac Catheterization Labs
- 7.5. Europe Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Germany Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.2. Germany Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.3. Germany Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.4. Germany Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.5. U.K. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.6. U.K. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.7. U.K. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.8. U.K. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.9. France Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.10. France Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.11. France Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.12. France Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.13. Italy Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.14. Italy Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.15. Italy Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.16. Italy Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.17. Turkey Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.18. Turkey Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.19. Turkey Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.20. Turkey Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.21. Russia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.22. Russia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.23. Russia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.24. Russia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.25. Rest of Europe Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.26. Rest of Europe Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.27. Rest of Europe Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.1.28. Rest of Europe Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Asia Pacific Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 8.1. Asia Pacific Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Peripheral Vascular Stents
- 8.1.1.1.1. Self-Expanding Stents
- 8.1.1.1.2. Balloon Expanding Stents
- 8.1.1.1.3. Covered Stents
- 8.1.1.1.4. Drug Eluting Stents
- 8.1.1.2. Drug Eluting Balloons
- 8.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 8.2. Asia Pacific Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Target Artery Instability (TAI)
- 8.2.1.2. Access Artery Injury (AAI)
- 8.2.1.3. Peripheral Arterial Disease
- 8.2.1.4. Arteriovenous Fistulas
- 8.2.1.5. Peripheral Aneurysms
- 8.2.1.6. Others
- 8.3. Asia Pacific Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Carotid Artery
- 8.3.1.2. Fem-Pop Artery
- 8.3.1.3. Iliac Artery
- 8.3.1.4. Infrapop Artery
- 8.4. Asia Pacific Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Hospitals
- 8.4.1.2. Ambulatory Surgical Centers/Outpatients
- 8.4.1.3. Cardiac Catheterization Labs
- 8.5. Asia Pacific Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. China Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.2. China Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.3. China Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.4. China Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.5. Japan Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.6. Japan Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.7. Japan Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.8. Japan Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.9. South Korea Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.10. South Korea Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.11. South Korea Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.12. South Korea Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.13. India Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.14. India Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.15. India Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.16. India Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.17. Southeast Asia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.18. Southeast Asia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.19. Southeast Asia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.20. Southeast Asia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.21. Rest of Asia Pacific Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.22. Rest of Asia Pacific Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.23. Rest of Asia Pacific Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.1.24. Rest of Asia Pacific Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Latin America Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 9.1. Latin America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.1.1. Key Highlights
- 9.1.1.1. Peripheral Vascular Stents
- 9.1.1.1.1. Self-Expanding Stents
- 9.1.1.1.2. Balloon Expanding Stents
- 9.1.1.1.3. Covered Stents
- 9.1.1.1.4. Drug Eluting Stents
- 9.1.1.2. Drug Eluting Balloons
- 9.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 9.2. Latin America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.2.1. Key Highlights
- 9.2.1.1. Target Artery Instability (TAI)
- 9.2.1.2. Access Artery Injury (AAI)
- 9.2.1.3. Peripheral Arterial Disease
- 9.2.1.4. Arteriovenous Fistulas
- 9.2.1.5. Peripheral Aneurysms
- 9.2.1.6. Others
- 9.3. Latin America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.3.1. Key Highlights
- 9.3.1.1. Carotid Artery
- 9.3.1.2. Fem-Pop Artery
- 9.3.1.3. Iliac Artery
- 9.3.1.4. Infrapop Artery
- 9.4. Latin America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.4.1. Key Highlights
- 9.4.1.1. Hospitals
- 9.4.1.2. Ambulatory Surgical Centers/Outpatients
- 9.4.1.3. Cardiac Catheterization Labs
- 9.5. Latin America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1. Key Highlights
- 9.5.1.1. Brazil Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.2. Brazil Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.3. Brazil Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.4. Brazil Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.5. Mexico Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.6. Mexico Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.7. Mexico Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.8. Mexico Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.9. Argentina Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.10. Argentina Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.11. Argentina Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.12. Argentina Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.13. Rest of Latin America Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.14. Rest of Latin America Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.15. Rest of Latin America Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.1.16. Rest of Latin America Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 9.5.2. BPS Analysis/Market Attractiveness Analysis
- 10. Middle East & Africa Peripheral Vascular Devices Market Outlook, 2018 – 2031
- 10.1. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.1.1. Key Highlights
- 10.1.1.1. Peripheral Vascular Stents
- 10.1.1.1.1. Self-Expanding Stents
- 10.1.1.1.2. Balloon Expanding Stents
- 10.1.1.1.3. Covered Stents
- 10.1.1.1.4. Drug Eluting Stents
- 10.1.1.2. Drug Eluting Balloons
- 10.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
- 10.2. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.2.1. Key Highlights
- 10.2.1.1. Target Artery Instability (TAI)
- 10.2.1.2. Access Artery Injury (AAI)
- 10.2.1.3. Peripheral Arterial Disease
- 10.2.1.4. Arteriovenous Fistulas
- 10.2.1.5. Peripheral Aneurysms
- 10.2.1.6. Others
- 10.3. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.3.1. Key Highlights
- 10.3.1.1. Carotid Artery
- 10.3.1.2. Fem-Pop Artery
- 10.3.1.3. Iliac Artery
- 10.3.1.4. Infrapop Artery
- 10.4. Middle East & Africa Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.4.1. Key Highlights
- 10.4.1.1. Hospitals
- 10.4.1.2. Ambulatory Surgical Centers/Outpatients
- 10.4.1.3. Cardiac Catheterization Labs
- 10.5. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1. Key Highlights
- 10.5.1.1. GCC Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.2. GCC Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.3. GCC Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.4. GCC Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.5. South Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.6. South Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.7. South Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.8. South Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.9. Egypt Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.10. Egypt Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.11. Egypt Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.12. Egypt Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.13. Nigeria Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.14. Nigeria Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.15. Nigeria Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.16. Nigeria Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.17. Rest of Middle East & Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.18. Rest of Middle East & Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.19. Rest of Middle East & Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.1.20. Rest of Middle East & Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 – 2031
- 10.5.2. BPS Analysis/Market Attractiveness Analysis
- 11. Competitive Landscape
- 11.1. Product vs Indication Heatmap
- 11.2. Company Market Share Analysis, 2023
- 11.3. Competitive Dashboard
- 11.4. Company Profiles
- 11.4.1. Abbott Laboratories
- 11.4.1.1. Company Overview
- 11.4.1.2. Product Portfolio
- 11.4.1.3. Financial Overview
- 11.4.1.4. Business Strategies and Development
- 11.4.2. Boston Scientific Corporation
- 11.4.2.1. Company Overview
- 11.4.2.2. Product Portfolio
- 11.4.2.3. Financial Overview
- 11.4.2.4. Business Strategies and Development
- 11.4.3. Cook Medical Inc.
- 11.4.3.1. Company Overview
- 11.4.3.2. Product Portfolio
- 11.4.3.3. Financial Overview
- 11.4.3.4. Business Strategies and Development
- 11.4.4. MicroPort Scientific Corporation (Endovastec™)
- 11.4.4.1. Company Overview
- 11.4.4.2. Product Portfolio
- 11.4.4.3. Financial Overview
- 11.4.4.4. Business Strategies and Development
- 11.4.5. Medtronic Plc.
- 11.4.5.1. Company Overview
- 11.4.5.2. Product Portfolio
- 11.4.5.3. Financial Overview
- 11.4.5.4. Business Strategies and Development
- 11.4.6. Cardinal Health, Inc
- 11.4.6.1. Company Overview
- 11.4.6.2. Product Portfolio
- 11.4.6.3. Financial Overview
- 11.4.6.4. Business Strategies and Development
- 11.4.7. B. Braun Melsungen AG
- 11.4.7.1. Company Overview
- 11.4.7.2. Product Portfolio
- 11.4.7.3. Financial Overview
- 11.4.7.4. Business Strategies and Development
- 11.4.8. BIOTRONIK SE & Co. KG
- 11.4.8.1. Company Overview
- 11.4.8.2. Product Portfolio
- 11.4.8.3. Financial Overview
- 11.4.8.4. Business Strategies and Development
- 11.4.9. Becton, Dickinson, and Company
- 11.4.9.1. Company Overview
- 11.4.9.2. Product Portfolio
- 11.4.9.3. Financial Overview
- 11.4.9.4. Business Strategies and Development
- 11.4.10. W. L. Gore & Associates Inc.
- 11.4.10.1. Company Overview
- 11.4.10.2. Product Portfolio
- 11.4.10.3. Financial Overview
- 11.4.10.4. Business Strategies and Development
- 11.4.11. Getinge AB
- 11.4.11.1. Company Overview
- 11.4.11.2. Product Portfolio
- 11.4.11.3. Financial Overview
- 11.4.11.4. Business Strategies and Development
- 11.4.12. Terumo Corp
- 11.4.12.1. Company Overview
- 11.4.12.2. Product Portfolio
- 11.4.12.3. Financial Overview
- 11.4.12.4. Business Strategies and Development
- 11.4.13. Kyoto Medical Planning Co Ltd
- 11.4.13.1. Company Overview
- 11.4.13.2. Product Portfolio
- 11.4.13.3. Financial Overview
- 11.4.13.4. Business Strategies and Development
- 11.4.14. iVascular S.L.U
- 11.4.14.1. Company Overview
- 11.4.14.2. Product Portfolio
- 11.4.14.3. Financial Overview
- 11.4.14.4. Business Strategies and Development
- 11.4.15. AMG International GmbH
- 11.4.15.1. Company Overview
- 11.4.15.2. Product Portfolio
- 11.4.15.3. Financial Overview
- 11.4.15.4. Business Strategies and Development
- 11.4.16. Endocor GmbH
- 11.4.16.1. Company Overview
- 11.4.16.2. Product Portfolio
- 11.4.16.3. Financial Overview
- 11.4.16.4. Business Strategies and Development
- 11.4.17. Meril Life Sciences Pvt. Ltd.
- 11.4.17.1. Company Overview
- 11.4.17.2. Product Portfolio
- 11.4.17.3. Financial Overview
- 11.4.17.4. Business Strategies and Development
- 11.4.18. Nano Therapeutics Pvt Ltd
- 11.4.18.1. Company Overview
- 11.4.18.2. Product Portfolio
- 11.4.18.3. Financial Overview
- 11.4.18.4. Business Strategies and Development
- 11.4.19. Koninklijke Philips N.V.
- 11.4.19.1. Company Overview
- 11.4.19.2. Product Portfolio
- 11.4.19.3. Financial Overview
- 11.4.19.4. Business Strategies and Development
- 11.4.20. REVA Medical
- 11.4.20.1. Company Overview
- 11.4.20.2. Product Portfolio
- 11.4.20.3. Financial Overview
- 11.4.20.4. Business Strategies and Development
- 12. Appendix
- 12.1. Research Methodology
- 12.2. Report Assumptions
- 12.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
